VENNER M;KERTH R;KLUG E,Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals,Veterinary Journal,2007.
[2]
BENCHAOUI H A;NOWAKOWSKI M;SHERJNGTON J,Pharmacokinetics and lung tissue concentrations of tulathromycin in swine,Pharmacology and Therapeutics,2004.
[3]
NOWAKOWSKI M A;INSKEEP P B;RISK J E,Pharmacokinetics and lung tissue concentrations of tulathromycin,a new triamilide antibiotic,in cattle,VETERINARY THERAPEUTICS,2004.
[4]
王玉爱,外伤应激时机体血液生化指标与血常规的变化,大连:大连医科大学,2008.
[5]
WASHBURN K E;BISSETT W;FAJT V,The safety of tulathro mycin administration in goats,Journal of Veterinary Pharmacology and Therapeutics,2007.
[6]
任纪平,如何正确把握贫血的分类和诊断,中国医疗前沿,2007(12).
[7]
张小东,环境对生长猪生理生化指标的影响,泰安:山东农业大学,2004.
[8]
KILGORE W R;SPENSLEY M S;SUN F S,Therapeutic effcacy of tulathromycin,a novel triamilide antimicrobial,against bovine respiratory disease in feeder calves,VETERINARY THERAPEUTICS,2005.
[9]
WELLMAN N G;CONNOR A M,Meta-analysis of treatment of cattle with bovine respiratory disease with tulathromycin,Journal of Veterinary Pharmacology and Therapeutics,2007.
[10]
SELLYEI B;VARGA Z;SZENTESI-SAMU K,Antimicrobial susceptibility of Pasteurella multocida isolated from swine and poultry,Acta Veterinaria Hungarica,2009(03).
